ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID.
作者信息
MCCHESNEY E W, FROELICH E J, LESHER G Y, CRAIN A V, ROSI D
出版信息
Toxicol Appl Pharmacol. 1964 May;6:292-309. doi: 10.1016/0041-008x(64)90070-5.
PMID:14194761
Abstract
摘要
相似文献
1
ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID.
Toxicol Appl Pharmacol. 1964 May;6:292-309. doi: 10.1016/0041-008x(64)90070-5.
2
BIOPHARMACEUTICAL INVESTIGATION OF NALIDIXIC ACID IN MAN.
J Pharm Sci. 1965 Jan;54:36-41. doi: 10.1002/jps.2600540109.
3
ABSORPTION, METABOLISM, AND EXCRETION OF OXAZEPAM AND ITS SUCCINATE HALF-ESTER.
J Pharm Sci. 1964 Oct;53:1181-6. doi: 10.1002/jps.2600531010.
4
[NEGRAM (NALIDIXIC ACID). CLINICAL INVESTIGATIONS OF A NEW ANTIBACTERIAL AGENT FOR URINARY TRACT INFECTIONS].
Ugeskr Laeger. 1964 Nov 19;126:1582-4.
5
A COMPARATIVE STUDY OF THE LEVELS OF NALIDIXIC ACID IN PLASMA AND URINE AND ITS ANTIBACTERIAL ACTIVITY IN URINARY INFECTIONS OF PARAPLEGICS.
Postgrad Med J. 1965 Aug;41(478):501-8. doi: 10.1136/pgmj.41.478.501.
6
[CLINICAL STUDY OF A NEW ANTIBACTERIAL AGENT: NALIDIXIC ACID].
Presse Med (1893). 1965 Jul 3;73:1909-10.
7
ANEW ANTIBACTERIAL AGENT FOR INFECTIONS OF THE GENITOURINARY TRACT: NALIDIXIC ACID.
JAMA. 1965 May 17;192:628-9.
8
A CLINICAL TRIAL WITH NALIDIXIC ACID ON 22 ACUTE AND CHRONIC URINARY TRACT INFECTIONS WITH FOLLOW-UP FOR 1-5 MONTHS.
Postgrad Med J. 1965 Aug;41(478):508-11. doi: 10.1136/pgmj.41.478.508.
9
[EXPERIENCE WITH NALIDIXIC ACID IN THE TREATMENT OF URINARY TRACT INFECTIONS].
Med Klin. 1964 Nov 6;59:1786-8.
10
STUDY OF NALIDIXIC ACID.
Invest Urol. 1965 Mar;2:409-16.
引用本文的文献
1
Nalidixic Acid: microbiological and clinical studies on urinary infections in children.
Arch Dis Child. 1966 Aug;41(218):389-94. doi: 10.1136/adc.41.218.389.
2
Distribution of gentamicin in body fluids.
Br Med J. 1968 Apr 6;2(5596):22-4. doi: 10.1136/bmj.2.5596.22.
3
TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.
Br Med J. 1965 Sep 11;2(5462):621-2. doi: 10.1136/bmj.2.5462.621.
4
A COMPARATIVE STUDY OF THE LEVELS OF NALIDIXIC ACID IN PLASMA AND URINE AND ITS ANTIBACTERIAL ACTIVITY IN URINARY INFECTIONS OF PARAPLEGICS.
Postgrad Med J. 1965 Aug;41(478):501-8. doi: 10.1136/pgmj.41.478.501.
5
Direct gradient reversed-phase HPLC analysis and preliminary pharmacokinetics of nalidixic acid, 7-hydroxymethylnalidixic acid, 7-carboxynalidixic acid, and their corresponding glucuronide conjugates in humans.
Pharm World Sci. 1993 Jun 18;15(3):98-104. doi: 10.1007/BF02113937.
6
Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment.
Pharm World Sci. 1993 Aug 20;15(4):165-70. doi: 10.1007/BF01880560.
7
Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
Experientia. 1980 Feb 15;36(2):243-4. doi: 10.1007/BF01953757.
8
Nalidixic acid kinetics in renal insufficiency.
Br J Clin Pharmacol. 1982 Oct;14(4):489-93. doi: 10.1111/j.1365-2125.1982.tb02017.x.
9
Selective antimicrobial modulation of the intestinal flora. Prophylaxis against infection in neutropenic patients.
Infection. 1984 Jan-Feb;12(1):1-4. doi: 10.1007/BF01641014.
10
Intracranial hypertension in a child during treatment with nalidixic acid.
Br Med J. 1967 Jun 17;2(5554):744-5. doi: 10.1136/bmj.2.5554.744.
Zotero 插件